🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT06586541
Recruiting Not applicable

The Family-ICU Trial

NCT06586541 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2024-11-18
Last updated
2026-08-14

Condition(s) studied

Family EngagementPatient and Family EngagementHealth Care DeliveryFamily-centered CarePhysician RoundsCritical Care, Intensive Care

Investigational drug(s) / intervention(s)

Participation in attending team rounds

Participation in attending team rounds: Family members participate in-person. If the family member wishes to participate in-person, they will be invited to be present when the team rounds in the ICU.

Study summary

Family inclusion in adult intensive care unit (ICU) rounds is recommended by critical care professional societies, yet widespread uptake of this practice is limited. A key barrier cited by ICU clinicians is insufficient evidence to support this practice. There is a need for robust evidence to support family participation in adult ICU rounds and influence change to routine clinical care. The primary purpose of this study is to assess whether family participation in adult ICU rounds improves family engagement in care. The secondary objectives are to assess family satisfaction, and anxiety and depression, to explore user experiences of family participation in ICU rounds, and to evaluate strategies to improve family member recruitment and retention rates. This is a stepped-wedge cluster randomized trial (n=194) at 6 Canadian ICUs. The stepped wedge cluster randomized trial is a pragmatic study design that overcomes methodological limitations in evaluating a healthcare service delivery intervention. In the stepped-wedge cluster design, there is random and sequential crossover of clusters from control (phase 1) to intervention (phase 2) until all clusters are exposed. The stepped-wedge design also allows each site to function as its own control. The stepped-wedge design is more powerful than a parallel design when substantial cluster level effects are present.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult family members (age ≥ 18 years) of ICU patients * Expected ICU stay ≥ 48 hours Exclusion Criteria: * Family members who do not wish to participate in care * Repeat admissions within the study period * Another family member has already participated in the study

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Jewish General Hospital Montreal Quebec Recruiting
McGill University Health Centre Montreal Quebec Recruiting

More Lady Davis Institute trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06586541 on ClinicalTrials.gov ↗ ← All trials in Canada